Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M528Revenue $M1,249Net Margin (%)-7.7Z-Score1.3
Enterprise Value $M555EPS $-3.1Operating Margin %-12.4F-Score4
P/E(ttm))0Cash Flow Per Share $23.4Pre-tax Margin (%)-12.3Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %0Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.45-y EBITDA Growth Rate %0Current Ratio0.6Lower Leverage y-yY
Price/Cash Flow0.5y-y EBITDA Growth Rate %0ROA % (ttm)-13.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-25.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.8ROI % (ttm)-16.6Gross Margin Increase y-yN

Gurus Latest Trades with AMED

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMEDCharles Brandes 2014-03-31 Reduce-0.01%$14.09 - $16.96
($15.31)
$ 16.417%Reduce -23.43%165,125
AMEDCharles Brandes 2013-03-31 Add0.03%$10.95 - $13.11
($11.61)
$ 16.4141%Add 515.74%225,885
AMEDCharles Brandes 2012-12-31 Buy $9.65 - $13.56
($11.33)
$ 16.4145%New holding, 36685 sh.36,685
AMEDJoel Greenblatt 2012-12-31 Sold Out -0.06%$9.65 - $13.56
($11.33)
$ 16.4145%Sold Out0
AMEDJoel Greenblatt 2012-09-30 Reduce-0.06%$11.3 - $15.84
($13.63)
$ 16.4120%Reduce -49.75%65,015
AMEDCharles Brandes 2012-09-30 Sold Out -0.0017%$11.3 - $15.84
($13.63)
$ 16.4120%Sold Out0
AMEDJohn Hussman 2012-06-30 Sold Out -0.04%$9.87 - $15.03
($12.43)
$ 16.4132%Sold Out0
AMEDJoel Greenblatt 2012-03-31 Add0.09%$9.56 - $14.66
($11)
$ 16.4149%Add 98.71%144,813
AMEDCharles Brandes 2012-03-31 Buy $9.56 - $14.66
($11)
$ 16.4149%New holding, 20195 sh.20,195
AMEDDavid Dreman 2011-12-31 Sold Out -0.5%$9.59 - $14.56
($11.75)
$ 16.4140%Sold Out0
AMEDGeorge Soros 2011-12-31 Sold Out -0.0041%$9.59 - $14.56
($11.75)
$ 16.4140%Sold Out0
AMEDCharles Brandes 2011-12-31 Sold Out -0.0021%$9.59 - $14.56
($11.75)
$ 16.4140%Sold Out0
AMEDJoel Greenblatt 2011-09-30 Add0.09%$13.29 - $27.55
($19.78)
$ 16.41-17%Add 125.99%64,379
AMEDGeorge Soros 2011-09-30 Reduce-0.07%$13.29 - $27.55
($19.78)
$ 16.41-17%Reduce -91.93%16,100
AMEDGeorge Soros 2011-06-30 Buy 0.07%$25.28 - $35.18
($30.9)
$ 16.41-47%New holding, 199599 sh.199,599
AMEDJoel Greenblatt 2011-06-30 Add0.02%$25.28 - $35.18
($30.9)
$ 16.41-47%Add 21.45%28,488
AMEDCharles Brandes 2011-06-30 Buy $25.28 - $35.18
($30.9)
$ 16.41-47%New holding, 14350 sh.14,350
AMEDRonald Muhlenkamp 2011-06-30 Sold Out -1.15%$25.28 - $35.18
($30.9)
$ 16.41-47%Sold Out0
AMEDMario Gabelli 2011-03-31 Sold Out $31.01 - $38.08
($34.76)
$ 16.41-53%Sold Out0
AMEDJoel Greenblatt 2011-03-31 Reduce-0.39%$31.01 - $38.08
($34.76)
$ 16.41-53%Reduce -60.67%23,456
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMED is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AMED Charles Brandes 2014-03-31165,1250.50.03-23.43%
Premium Most recent portfolio changes are included for Premium Members only!


AMED: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NORTH TIDE CAPITAL, LLC10% Owner 2014-05-08Buy500,000$13.915.68view
NORTH TIDE CAPITAL, LLC10% Owner 2014-05-01Buy150,000$13.5418.76view
RICCHIUTI PETERDirector 2014-04-02Sell375$15.315.03view
RICCHIUTI PETERDirector 2014-03-04Sell400$16.67-3.54view
RICCHIUTI PETERDirector 2013-12-03Sell375$15.891.2view
KKR Asset Management LLC10% Owner 2013-11-21Buy425,515$14.4811.05view
Bucey David RGeneral Counsel and Secretary 2013-11-15Sell8,290$13.9515.27view
KKR Asset Management LLC10% Owner 2013-11-14Buy946,500$13.8915.77view
KKR Asset Management LLC10% Owner 2013-10-30Buy29,615$15.940.88view
KKR Asset Management LLC10% Owner 2013-10-22Buy186,013$17.55-8.38view

Press Releases about AMED :

    Quarterly/Annual Reports about AMED:

    News about AMED:

    Articles On GuruFocus.com
    comment on AMED Jun 20 2012 
    well undervalued, st Jan 24 2012 
    “Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
    AMED: Investment Opportunity When the Price Hits an 8-Year Low Dec 27 2011 
    Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
    guru bargain Oct 05 2011 
    Magic Formula Stock: Amedisys (AMED) Aug 05 2011 
    Home Healthcare: Heavily Shorted long Opportunity May 30 2011 
    Amedisys Inc (AMED) CFO Dale E Redman buys 1,000 Shares Aug 25 2010 
    Amedisys Inc Reports Operating Results (10-Q) Aug 09 2010 

    More From Our Partners
    Gentiva (GTIV) Worth Watching: Stock Gains 16.1% - Tale of the Tape Jul 21 2014 - ZACKS

    More From Other Websites
    DaVita's Domestic Acquisitions Look Good, Debt Lingers Jul 18 2014
    Universal Health Services (UHS) Jumps: Stock Up 5.6% Jul 17 2014
    Earnings Estimates Moving Higher for Amedisys (AMED): Time to Buy? Jul 10 2014
    Amedisys Announces Completion of SEC Investigation Jul 08 2014
    [$$] Amedisys Says No SEC Enforcement Action Planned Jul 08 2014
    AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jul 08 2014
    Amedisys Announces Completion of SEC Investigation Jul 08 2014
    Kindred urges Gentiva shareholders to vote for buyout offer Jul 01 2014
    Amedisys (AMED) Highlighted As Today's Perilous Reversal Stock Jun 30 2014
    Can the Uptrend Continue for Amedisys (AMED)? Jun 30 2014
    Kindred Healthcare sends letter to Gentiva Health board Jun 27 2014
    Stocks Mildly Higher To End The Week Jun 27 2014
    Midday movers: Dollar General, DuPont, Nike & More Jun 27 2014
    Why Amedisys (AMED) Stock Is Gaining Today Jun 27 2014
    Amedisys Previews Second Quarter 2014 Results Jun 27 2014
    Amedisys Previews Second Quarter 2014 Results Jun 27 2014
    AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 27 2014
    Gentiva Hits 52-Week High on Inorganic Growth & Cost Control Jun 18 2014
    AMEDISYS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 06 2014
    Is Amedisys (AMED) Stock a Solid Choice Right Now? Jun 06 2014
    Amedisys to Present at the Jefferies 2014 Global Healthcare Conference May 28 2014
    Feds: Amedisys paying $150 million settlement Apr 23 2014
    Amedisys Expands Its Board of Directors with Appointment of KKR’s Nathaniel M. Zilkha Mar 27 2014
    Amedisys Announces Appointment of Dale E. Redman as Interim Chief Financial Officer Mar 19 2014
    Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Mar 05 2014
    Amedisys Chairman & CEO William Borne Steps Down Feb 24 2014
    Increasing Health Care at Home Integral to Success of the Affordable Care Act Jan 22 2014
    A Tribute to Gabrielle Giffords and Rehab Therapists Everywhere Jan 13 2014
    Amedisys to Present at the 32nd Annual J.P. Morgan Healthcare Conference Jan 09 2014
    2013 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide Dec 18 2013
    Amedisys to Present at the 24th Annual Oppenheimer Healthcare Conference Dec 05 2013
    Amedisys to Present at the Credit Suisse 2013 Healthcare Conference Nov 13 2013
    Amedisys Reports Third Quarter Financial Results Nov 12 2013
    Amedisys Executive Vice President of Operations Patrick Thompson Presented Smarter Care Transitions... Nov 11 2013
    New Study by Amedisys and Purdue University Shows Medication Management Interventions Reduced... Nov 06 2013
    Amedisys Announces Third Quarter Earnings Release and Conference Call Date Nov 05 2013
    Survey Shows a New Model of Care Emerging as Hospitals Focus on Reducing Preventable Readmissions Oct 30 2013

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide